Wed, March 15, 2023

Colin Bristow Maintained (ALXO) at Strong Buy with Decreased Target to $29 on, Mar 15th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-29-on-mar-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Colin Bristow of UBS, Maintained "ALX Oncology Holdings Inc." (ALXO) at Strong Buy with Decreased Target from $31 to $29 on, Mar 15th, 2023.

Colin has made no other calls on ALXO in the last 4 months.



There are 2 other peers that have a rating on ALXO. Out of the 2 peers that are also analyzing ALXO, 0 agree with Colin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Colin


  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Friday, March 10th, 2023
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $34 on, Friday, March 10th, 2023